# Ring Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ring-therapeutics

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.ringtx.com
- Total disclosed funding: $156M
- Latest round: Series C (Oct 6, 2022)
- Investors on record: 9

## About

Based in Massachusetts, US, and founded by Avak Kahvejian, Erica Weinstein, and Noubar Afeyan in 2017, Ring Therapeutics, Inc. operates as a biotechnology company that uses human biology commensal virome to create a gene therapy platform. In October 2022, Ring Therapeutics, Inc. raised USD 71.50 million in Series C funding from Alexandria Venture Investments, CJ Investment Partners LLC, and Kyowa Kirin. The series C funding values Ring Therapeutics, Inc. at USD 561.16 million post-money. As of 2025, the company is led by its CEO Christopher McNulty.

Ring Therapeutics provides Anellogy™ platform, which utilizes the properties of anelloviruses to create a pipeline of redosable vectors compatible with the human immune system to target specific tissues and produce programmable medicines. The platform enables the application of DNA-based treatments for gene replacement, targeting genetic disorders, ophthalmology, oncology, metabolic disorders, etc., enabling the healthcare industry to provide therapeutics based on their specific diseases. The company uses Anelloscope™, for detecting, identifying, and tracking unique anelloviruses and their subtypes.

## Funding rounds

- Series C, Oct 6, 2022, $72M — Flagship Pioneering, T Rowe Price, Alexandria Venture Investments, Invus [DUP], Altitude Life Science Ventures, Partners Investment, UPMC Enterprises, Kyowa Kirin, CJ Investment Partners LLC
- Series B, Feb 25, 2021, $59M — Flagship Pioneering, T Rowe Price, Invus [DUP], Altitude Life Science Ventures, Partners Investment, UPMC Enterprises
- Series A, Jan 3, 2020, $25M — Flagship Pioneering

## Investors

- Flagship Pioneering (https://capitalatlas.ai/funds/flagship-pioneering) — Series A, Series B, Series C
- T Rowe Price (https://capitalatlas.ai/funds/t-rowe-price) — Series B, Series C
- Invus [DUP] — Series B, Series C
- Altitude Life Science Ventures (https://capitalatlas.ai/funds/altitude-life-science-ventures) — Series B, Series C
- Partners Investment (https://capitalatlas.ai/funds/partners-investment) — Series B, Series C
- UPMC Enterprises (https://capitalatlas.ai/funds/upmc-enterprises) — Series B, Series C
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series C
- Kyowa Kirin — Series C
- CJ Investment Partners LLC — Series C